問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
塗昆樺
下載
2025-07-01 - 2028-12-31
Condition/Disease
-Change from baseline in seated Systolic Blood Pressure (SBP) at Week 8 -Achieving normalization of the Renin Angiotensin Aldosterone system (RAAS) at week 8
Test Drug
Baxdrostat
Participate Sites6Sites
Recruiting6Sites
2025-06-13 - 2030-06-30
Primary Membranous Nephropathy (PMN)
powder
Participate Sites10Sites
Recruiting10Sites
2025-04-01 - 2029-09-30
Immunoglobulin A nephropathy (IgA nephropathy, IgAN)
Felzartamab
Participate Sites8Sites
Recruiting8Sites
2018-10-01 - 2026-12-31
Participate Sites11Sites
Recruiting11Sites
2018-12-01 - 2029-05-31
Participate Sites4Sites
Recruiting4Sites
2019-11-01 - 2026-04-04
2021-10-01 - 2029-04-30
Participate Sites7Sites
Not yet recruiting1Sites
2021-02-01 - 2025-12-31
2021-07-15 - 2026-12-31
Participate Sites2Sites
Recruiting1Sites
2025-09-30 - 2029-12-31
xxxxxx
全部
